Hedgehog inhibitors (HHis) target the hedgehog pathway to decrease the expression of various proteins such as GLI family zinc finger 1 (GLI1), cyclins and MYC, which leads to reduced tumor cell survival, increased immune infiltration, and tumor remission [4,5,6,7,8,9] (see Figure 1). Here, GLI1 is linked to neoplasm.